Administration of phospholipide hepatoprotective drug Phosphogliv in patients with psoriatic arthritis (preliminary results)

Considering membrane-reparative properties of a new phospholipid hepatoprotector Phosphogliv (FG) its therapeutic efficacy was assessed in 9 pts with psoriatic arthritis (PA) accompanied by prominent disturbances of blood rheology. FG was given 0,6 g a day during 3 months. Significant decrease of er...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Korotaeva, E. L. Nassonov, O. M. Ipatova, N N Firsov, O A Fvkina, TA Torhovskaya, A. I. Archakov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2004-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1307
Tags: Add Tag
No Tags, Be the first to tag this record!